E-ring isoprostanes stimulate a Cl- conductance in airway epithelium via prostaglandin E2-selective prostanoid receptors

American Journal of Respiratory Cell and Molecular Biology

Volumn 38, Issue 1, 2008, Pages 88-94

  Seto, Victoria ^a   Hirota, Christina ^a   Hirota, Simon ^a   Janssen, Luke J ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Chloride conductance; Isoprostane; Oxidative stress; Prostanoid receptor; Secretion

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; 6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ADENYLATE CYCLASE INHIBITOR; AMILORIDE; BUMETANIDE; CHLORIDE; FLUPROSTENOL; FUROSEMIDE; GUANYLATE CYCLASE INHIBITOR; ISOPROSTANE DERIVATIVE; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE; NIFLUMIC ACID; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTANOID RECEPTOR; QUINOXALINE DERIVATIVE; RECEPTOR BLOCKING AGENT; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SULPROSTONE;

ANIMAL TISSUE; ARTICLE; CHLORIDE CONDUCTANCE; CHLORIDE CURRENT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; NONHUMAN; RESPIRATORY EPITHELIUM; SODIUM CONDUCTANCE;

ANIMALS; CATTLE; CHLORIDE CHANNELS; ELECTRIC CONDUCTIVITY; EVOKED POTENTIALS; ION TRANSPORT; ISOPROSTANES; MEMBRANE LIPIDS; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, PROSTAGLANDIN E; RESPIRATORY MUCOSA; TISSUE CULTURE TECHNIQUES; TRACHEA;

BOVINAE;

EID: 37549069747     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0117OC     Document Type: Article

References (50)

1. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001;280: L1067-L1082.
2. 2- isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-1203.
3. 2a-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci USA 1998;95:3449-3454.
4. 2a in the airways of human subjects. Am J Respir Cell Mol Biol 1993;9:568-572.
5. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162:1175-1177.
6. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003;58:505-509.
7. Baraldi E, Ghiro L, Piovan V, Carraro S, Ciabattoni G, Barnes PJ, Montuschi P. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003;124:25-31.
8. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002; 165:1364-1370.
9. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216-220.
10. 2a isoprostane in cystic fibrosis. Lipids 1999;34:551-556.
11. Montuschi P, Kharitonov SA, Ciabattoni G, Corradi M, van Rensen L, Geddes DM, Hodson ME, Barnes PJ. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000;55:205-209.
12. 4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003;58:294-298.
13. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003;124:1373-1380.
14. 2a-III, an index of oxidant stress. Am J Respir Crit Care Med 1998;158:1709-1714.
15. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003;124:1386-1392.
16. Cowley EA. Isoprostane-mediated secretion from human airway epithelial cells. Mol Pharmacol 2003;64:298-307.
17. Janssen LJ, Premji M, Netherton S, Catalli A, Cox G, Keshavjee S, Crankshaw DJ. Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle. J Pharmacol Exp Ther 2000;295:506-511.
18. Janssen LJ, Premji M, Netherton S, Coruzzi J, Lu-Chao H, Cox PG. Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles. Br J Pharmacol 2001;132:127-134.
19. Tazzeo T, Miller J, Janssen LJ. Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle. Br J Pharmacol 2003;140:759-763.
20. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-9387.
21. 2 in porcine coronary artery. J Pharmacol Exp Ther 2003;305:1054-1060.
22. 2a in anaesthetised guinea pigs. Pharmacol Res 1998;37:75-80.
23. 2. Am J Physiol Lung Cell Mol Physiol 2004;287:L1035-L1041.
24. Catalli A, Zhang D, Janssen LJ. Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002;283: L1151-L1159.
25. 3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 2002;301:1060-1066.
26. Jourdan KB, Mitchell JA, Evans TW. Release of isoprostanes by human pulmonary artery in organ culture: a cyclo-oxygenase and nitric oxide dependent pathway. Biochem Biophys Res Commun 1997;233:668-672.
27. 2a is a potent contractor of human peripheral lymphatics. Lymphology 1997;30:155-159.
28. Clarke DL, Giembycz MA, Patel HJ, Belvisi MG. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Br J Pharmacol 2004;141:600-609.
29. 2a on acetylcholine release from parasympathetic nerves in guinea pig airways. Eur J Pharmacol 2001;416:231-234.
30. Scholz H, Yndestad A, Damas JK, Waehre T, Tonstad S, Aukrust P, Halvorsen B. 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases. Cardiovasc Res 2003;59:945-954.
31. 2-III). Prostaglandins Other Lipid Mediat 1999;57:319-331.
32. Nadel JA, Davis B, Phipps RJ. Control of mucus secretion and ion transport in airways. Annu Rev Physiol 1979;41:369-381.
33. Widdicombe JH. Fluid transport across airway epithelia. Ciba Found Symp 1984;109:109-120.
34. Corrales RJ, Coleman DL, Jacoby DB, Leikauf GD, Hahn HL, Nadel JA, Widdicombe JH. Ion transport across cat and ferret tracheal epithelia. J Appl Physiol 1986;61:1065-1070.
35. Durand J, Durand-Arczynska W, Vulliemin P. Current-induced volume flow across bovine tracheal epithelium: evidence for sodium-water coupling. J Physiol 1984;348:19-34.
36. Vulliemin P, Durand-Arczynska W, Durand J. Electrical properties and electrolyte transport in bovine tracheal epithelium: effects of ion substitutions, transport inhibitors and histamine. Pflugers Arch 1983; 396:54-59.
37. Widdicombe JH, Widdicombe JG. Regulation of human airway surface liquid. Respir Physiol 1995;99:3-12.
38. Fuller CM, Ji HL, Tousson A, Elble RC, Pauli BU, Benos DJ. Ca(2+)-activated Cl(-) channels: a newly emerging anion transport family. Pflugers Arch 2001;443:S107-S110.
39. Brown GR, Foubister AJ, Hudson JA. Improved synthetic routes to the novel thromboxane receptor antagonist ICI 192605: activity of synthetic 1,3-dioxane intermediates. J Pharm Pharmacol 1990;42:53-55.
40. Keery RJ, Lumley P. AH6809, a prostaglandin DP-receptor blocking drug on human platelets. Br J Pharmacol 1988;94:745-754.
41. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997;122:217-224.
42. Sanner JH. Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11- dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220). Arch Int Pharmacodyn Ther 1969;180:46-56.
43. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193-1226.
44. 2a (FP) receptor. J Pharmacol Exp Ther 1999;290: 1278-1284.
45. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001; 41:661-690.
46. Silinsky EM, Vogel SM. The effects of an adenylate cyclase inhibitor on the electrophysiological correlates of neuromuscular transmission in the frog. Br J Pharmacol 1986;88:799-805.
47. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 1995;48:184-188.
48. Cowley EA, Linsdell P. Oxidant stress stimulates anion secretion from the human airway epithelial cell line Calu-3: implications for cystic fibrosis lung disease. J Physiol 2002;543:201-209.
49. 2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Exp Mol Med 2005;37:588-600.
50. Clarke DM, Giembycz MA, Yacoub MH, Belvisi MG. Regulation of the release of colony stimulating factors from human airway smooth muscle cells by isoprostanes. Am J Respir Crit Care Med 2002:165:A114.